Sangamo Therapeutics首席财务官退休

2025-09-12 21:03

Shares of Sangamo Therapeutics (NASDAQ:SGMO) fell on Friday after the company's chief financial officer, Prathyusha Duraibabu, notified of her decision to resign, effective October 1.
The resignation decision is in order to assume a senior leadership role with a privately-held artificial intelligence company, Sangamo said in a filing.
On October 1, Duraibabu will transition to part-time employment, following which she will continue to serve as principal financial officer on an interim basis till a successor is named.
The stock of the company is down 4% premarket.

More on Sangamo Therapeutics